Nuveen Asset Management’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $341K | Sell |
28,938
-101,232
| -78% | -$1.19M | ﹤0.01% | 3099 |
|
2024
Q3 | $2.69M | Buy |
130,170
+102,272
| +367% | +$2.11M | ﹤0.01% | 2280 |
|
2024
Q2 | $1.26M | Buy |
+27,898
| New | +$1.26M | ﹤0.01% | 2614 |
|
2021
Q2 | – | Sell |
-8,437
| Closed | -$2.34M | – | 3324 |
|
2021
Q1 | $2.34M | Buy |
8,437
+270
| +3% | +$74.9K | ﹤0.01% | 2543 |
|
2020
Q4 | $2.27M | Hold |
8,167
| – | – | ﹤0.01% | 2444 |
|
2020
Q3 | $2.27M | Sell |
8,167
-17,371
| -68% | -$4.82M | ﹤0.01% | 2315 |
|
2020
Q2 | $6.43M | Buy |
25,538
+17,122
| +203% | +$4.31M | ﹤0.01% | 1757 |
|
2020
Q1 | $1.32M | Buy |
8,416
+1,612
| +24% | +$253K | ﹤0.01% | 2388 |
|
2019
Q4 | $1.11M | Hold |
6,804
| – | – | ﹤0.01% | 2648 |
|
2019
Q3 | $994K | Sell |
6,804
-390
| -5% | -$57K | ﹤0.01% | 2707 |
|
2019
Q2 | $1.5M | Buy |
+7,194
| New | +$1.5M | ﹤0.01% | 2567 |
|